Three weeks into @projectn95’s COVID-19 rapid response efforts. After conducting sourcing due diligence of hundreds of suppliers and product submissions, the numbers are startling 1/

To date, only 1.6% of the products submitted have successfully completed our vetting process. In comparison, @harvard acceptance rate is 5.2% 2/

Our approach is industry standard, known best-practices sourcing workflows. Success isn’t measured in pass rate, but standard supplier performance = quality, cost, delivery. Rejected products and the reasons WHY are most important. 3/

For healthcare providers, poor supplier performance and bad product quality results in more COVID-19 cases and potential deaths.

How are you validating your supplier sources? 4/